Marian Freedman


Does diet really play a role in acne?

For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.

Peter Baek


An Overview of Argyria

Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.

Melinda Gooderham, MSc, MD, FRCPC


New Drugs in 2023, Patient Satisfaction, and RAD Takeaways With Melinda Gooderham, MSc, MD, FRCPC

Gooderham’s sessions covered upcoming AD drug approvals, patient satisfaction and QoL improvement, and RAD 2023 takeaways.

Jeremy D. Sherer, JD


Telehealth in 2023: What Physicians Need to Know

Answers to some common questions about providing telehealth services in 2023.

Glynis Ablon, MD


Glynis Ablon, MD, Reviews the Latest Innovative Treatment Pearls for Hair Loss

Ablon presented sessions on nutrition, exosome therapy, and treating the hair-challenged patient at SCALE 2023.

Joel M. Gelfand, MD, MSCE, FAAD


Addressing Patients' Concerns With Biosimilars

Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.

Heidi Anne Duerr, MPH


Annual Meeting Session Highlights Clinical Pearls in Medical Dermatology

A key session at the annual meeting will share practical advice and tools to better support you and your patients.

Benjamin Lockshin, MD, FAAD


Patient Case #1: 29-Year-Old Female With Plaque Psoriasis

Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.

Hilary Baldwin, MD


Expert Insights into the Safety of Isotretinoin

An expert in dermatology reviews the differences in Isotretinoin and highlights how this treatment is both highly efficacious and safe when administered and monitored properly.

Courtney Marabella


Topical Remetinostat Effective, Tolerable in Basal Cell Carcinoma

The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.

Adam Braunscheidel, CFP


Rule 1 for Investing During Volatile Markets: Stick to Your Plan

In this month's financial planning column, the OJM group talks about volatile markets and how to navigate investing in uncertain times.

Elizabeth Swanson, MD


Patient Case #1: AD Treatment Options

Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.

Giuliana Grossi


Pregnancy outcomes vary in women with psoriatic arthritis

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.

Jason Luke, MD, FACP


New Long-Term KEYNOTE-716 Data Presented at ASCO 2023

Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.

Gina Mauro


FDA Grants Orphan Drug Status to ITIL-168 for Melanoma

The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.

Kristina Collins, MD


Designing Your Practice With Kristina Collins, MD

Collins said an office environment impacts outcomes and shared office design considerations.

Carrie Nagorka, Senior Editor


Preparing Patients for the Summer Sun: Location, Location, Location

Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.

Brandon May


Acne Flares May be Worsened by Climate Change

Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.

Sherry G. Cohen, NP-C


Treating Seborrheic Dermatitis

A look at the common condition and how to treat it.

Amit Pandya, MD


Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAAD

Pandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.

Raj Chovatiya, MD, PhD


Upadacitinib, Long-Term Control, and Tapinarof, Oh My!

Raj Chovatiya, MD, PhD, discusses highlights from his sessions at RAD 2023 on best practices for AD management.

Ron Southwick


Female physicians earn millions less than male counterparts, new report finds

A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.

Victor L. Quan, MD


Acne Update: 2022’s Top 5 Trends

Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.

© 2023 MJH Life Sciences

All rights reserved.